The global market for Dapsone was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
The 2025 U.S. tariff policies introduce profound uncertainty into the global economic landscape. This report critically examines the implications of recent tariff adjustments and international strategic countermeasures on Dapsone competitive dynamics, regional economic interdependencies, and supply chain reconfigurations.
Dapsone is a chemical substance that is mainly used in the medical field and has antibacterial and anti-inflammatory properties. It has a molecular weight of 266.28 and is usually present in the form of a white or off-white crystalline powder, which is odorless and tasteless. It is a nitrodiaminopyrimidine antibacterial drug that is mainly used to treat diseases such as leprosy, pemphigus vegetative and dermatitis herpetiformis. Dapsone works by inhibiting the folate metabolism of bacteria and is effective against a variety of Gram-positive bacteria and certain protozoa. In addition to its applications in the medical field, dapsone is also used as a component of antimalarial drugs and in some cases for the prevention of malaria. Due to its antibacterial and anti-inflammatory properties, dapsone also has important applications in dermatology, especially in the treatment of certain serious skin diseases. With the increase in attention to chronic inflammatory diseases and infectious diseases, the market demand for dapsone continues to grow in the medical field.
Market Development Opportunities & Main Driving Factors
The Dapsone market has witnessed significant development opportunities in recent years, primarily due to its effectiveness in various medical applications. In the treatment of leprosy, Dapsone is one of the key drugs in the World Health Organization (WHO) - recommended multidrug therapy, driving its global demand. Additionally, increased awareness and improved diagnosis of chronic skin diseases such as pemphigus vulgaris and herpetiform dermatitis have led to a growing need for their treatment. The effective application of Dapsone in these diseases has further expanded its market. Moreover, the rise of drug-resistant bacteria has drawn more attention to Dapsone in certain antimicrobial therapies, especially in treating drug-resistant skin infections. With the global aging population and rising prevalence of chronic diseases, demand for Dapsone in the medical sector will continue to grow, particularly in developing countries where the treatment needs for leprosy and other infectious diseases remain high.
Market Challenges, Risks, & Restraints
Despite its promising prospects, the Dapsone market faces several challenges and risks. First, Dapsone use may cause side effects and adverse reactions such as hemolytic anemia, methemoglobinemia, and peripheral neuropathy, potentially limiting its use in specific patient groups. Additionally, the ongoing development of new antimicrobial drugs and therapies poses a risk of market share erosion for Dapsone, as these new drugs may offer better efficacy or fewer side effects in some cases. Moreover, strict pharmaceutical regulations and approval processes can impact Dapsone's market entry and promotion. Regulatory differences between countries may create market entry barriers. Finally, global economic uncertainties and changes in trade policies may adversely affect Dapsone's market demand and prices.
Downstream Demand Trends
Looking at downstream demand, Dapsone has broad prospects in multiple medical fields. In dermatology, as understanding of autoimmune and chronic inflammatory skin diseases deepens, Dapsone's role in treating them will continue to be valued. In antimalarial applications, despite Dapsone's primary use in preventing and treating specific malaria types, its role in combination therapies may grow due to drug-resistant parasites. Also, in veterinary medicine, Dapsone's use in treating certain animal diseases offers additional market growth opportunities. In the future, research into new Dapsone indications may expand its applications. Continuous R & D and improvement in the pharmaceutical industry will enhance Dapsone's efficacy and safety, bolstering its market competitiveness.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Dapsone, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Dapsone.
The Dapsone market size, estimations, and forecasts are provided in terms of output/shipments (K MT) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Dapsone market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Dapsone manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, production, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
By Company
TCI
HBCChem
Alfa Chemistry
Anvia Chemicals
Ivy Fine Chemicals
AlliChem
Waterstone Technology
Acros Organics
3B Scientific
EDQM
J & K SCIENTIFIC
Hubei Yuancheng Saichuang Technology
Guangzhou Kafen Biotech
Nuray Chemicals
Cohance Lifesciences
HRV Global Life Sciences
Atul Limited
Chongqing Huapont Pharmaceutical
Dipharma
Lundbeck Pharma
Corden Pharma
Macleods Pharmaceuticals
Healthy Life Pharma
Segment by Type
Purity 99%
Purity 99.5%
Others
Segment by Application
Chemical Reagents
Pharmaceutical Intermediates
Others
Production by Region
North America
Europe
China
Japan
Consumption by Region
North America
U.S.
Canada
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Europe
Germany
France
U.K.
Italy
Russia
Latin America
Mexico
Brazil
Argentina
Middle East and Africa
Turkey
Saudi Arabia
U.A.E
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Dapsone manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Production/output, value of Dapsone by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 4: Consumption of Dapsone in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 5: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: The main points and conclusions of the report.
Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.
1 Dapsone Market Overview
1.1 Product Definition
1.2 Dapsone by Type
1.2.1 Global Dapsone Market Value Growth Rate Analysis by Type: 2024 VS 2031
1.2.2 Purity 99%
1.2.3 Purity 99.5%
1.2.4 Others
1.3 Dapsone by Application
1.3.1 Global Dapsone Market Value Growth Rate Analysis by Application: 2024 VS 2031
1.3.2 Chemical Reagents
1.3.3 Pharmaceutical Intermediates
1.3.4 Others
1.4 Global Market Growth Prospects
1.4.1 Global Dapsone Production Value Estimates and Forecasts (2020-2031)
1.4.2 Global Dapsone Production Capacity Estimates and Forecasts (2020-2031)
1.4.3 Global Dapsone Production Estimates and Forecasts (2020-2031)
1.4.4 Global Dapsone Market Average Price Estimates and Forecasts (2020-2031)
1.5 Assumptions and Limitations
2 Market Competition by Manufacturers
2.1 Global Dapsone Production Market Share by Manufacturers (2020-2025)
2.2 Global Dapsone Production Value Market Share by Manufacturers (2020-2025)
2.3 Global Key Players of Dapsone, Industry Ranking, 2023 VS 2024
2.4 Global Dapsone Company Type and Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.5 Global Dapsone Average Price by Manufacturers (2020-2025)
2.6 Global Key Manufacturers of Dapsone, Manufacturing Base Distribution and Headquarters
2.7 Global Key Manufacturers of Dapsone, Product Offered and Application
2.8 Global Key Manufacturers of Dapsone, Date of Enter into This Industry
2.9 Dapsone Market Competitive Situation and Trends
2.9.1 Dapsone Market Concentration Rate
2.9.2 Global 5 and 10 Largest Dapsone Players Market Share by Revenue
2.10 Mergers & Acquisitions, Expansion
3 Dapsone Production by Region
3.1 Global Dapsone Production Value Estimates and Forecasts by Region: 2020 VS 2024 VS 2031
3.2 Global Dapsone Production Value by Region (2020-2031)
3.2.1 Global Dapsone Production Value by Region (2020-2025)
3.2.2 Global Forecasted Production Value of Dapsone by Region (2026-2031)
3.3 Global Dapsone Production Estimates and Forecasts by Region: 2020 VS 2024 VS 2031
3.4 Global Dapsone Production Volume by Region (2020-2031)
3.4.1 Global Dapsone Production by Region (2020-2025)
3.4.2 Global Forecasted Production of Dapsone by Region (2026-2031)
3.5 Global Dapsone Market Price Analysis by Region (2020-2025)
3.6 Global Dapsone Production and Value, Year-over-Year Growth
3.6.1 North America Dapsone Production Value Estimates and Forecasts (2020-2031)
3.6.2 Europe Dapsone Production Value Estimates and Forecasts (2020-2031)
3.6.3 China Dapsone Production Value Estimates and Forecasts (2020-2031)
3.6.4 Japan Dapsone Production Value Estimates and Forecasts (2020-2031)
4 Dapsone Consumption by Region
4.1 Global Dapsone Consumption Estimates and Forecasts by Region: 2020 VS 2024 VS 2031
4.2 Global Dapsone Consumption by Region (2020-2031)
4.2.1 Global Dapsone Consumption by Region (2020-2025)
4.2.2 Global Dapsone Forecasted Consumption by Region (2026-2031)
4.3 North America
4.3.1 North America Dapsone Consumption Growth Rate by Country: 2020 VS 2024 VS 2031
4.3.2 North America Dapsone Consumption by Country (2020-2031)
4.3.3 U.S.
4.3.4 Canada
4.4 Europe
4.4.1 Europe Dapsone Consumption Growth Rate by Country: 2020 VS 2024 VS 2031
4.4.2 Europe Dapsone Consumption by Country (2020-2031)
4.4.3 Germany
4.4.4 France
4.4.5 U.K.
4.4.6 Italy
4.4.7 Russia
4.5 Asia Pacific
4.5.1 Asia Pacific Dapsone Consumption Growth Rate by Region: 2020 VS 2024 VS 2031
4.5.2 Asia Pacific Dapsone Consumption by Region (2020-2031)
4.5.3 China
4.5.4 Japan
4.5.5 South Korea
4.5.6 China Taiwan
4.5.7 Southeast Asia
4.5.8 India
4.6 Latin America, Middle East & Africa
4.6.1 Latin America, Middle East & Africa Dapsone Consumption Growth Rate by Country: 2020 VS 2024 VS 2031
4.6.2 Latin America, Middle East & Africa Dapsone Consumption by Country (2020-2031)
4.6.3 Mexico
4.6.4 Brazil
4.6.5 Turkey
4.6.6 GCC Countries
5 Segment by Type
5.1 Global Dapsone Production by Type (2020-2031)
5.1.1 Global Dapsone Production by Type (2020-2025)
5.1.2 Global Dapsone Production by Type (2026-2031)
5.1.3 Global Dapsone Production Market Share by Type (2020-2031)
5.2 Global Dapsone Production Value by Type (2020-2031)
5.2.1 Global Dapsone Production Value by Type (2020-2025)
5.2.2 Global Dapsone Production Value by Type (2026-2031)
5.2.3 Global Dapsone Production Value Market Share by Type (2020-2031)
5.3 Global Dapsone Price by Type (2020-2031)
6 Segment by Application
6.1 Global Dapsone Production by Application (2020-2031)
6.1.1 Global Dapsone Production by Application (2020-2025)
6.1.2 Global Dapsone Production by Application (2026-2031)
6.1.3 Global Dapsone Production Market Share by Application (2020-2031)
6.2 Global Dapsone Production Value by Application (2020-2031)
6.2.1 Global Dapsone Production Value by Application (2020-2025)
6.2.2 Global Dapsone Production Value by Application (2026-2031)
6.2.3 Global Dapsone Production Value Market Share by Application (2020-2031)
6.3 Global Dapsone Price by Application (2020-2031)
7 Key Companies Profiled
7.1 TCI
7.1.1 TCI Dapsone Company Information
7.1.2 TCI Dapsone Product Portfolio
7.1.3 TCI Dapsone Production, Value, Price and Gross Margin (2020-2025)
7.1.4 TCI Main Business and Markets Served
7.1.5 TCI Recent Developments/Updates
7.2 HBCChem
7.2.1 HBCChem Dapsone Company Information
7.2.2 HBCChem Dapsone Product Portfolio
7.2.3 HBCChem Dapsone Production, Value, Price and Gross Margin (2020-2025)
7.2.4 HBCChem Main Business and Markets Served
7.2.5 HBCChem Recent Developments/Updates
7.3 Alfa Chemistry
7.3.1 Alfa Chemistry Dapsone Company Information
7.3.2 Alfa Chemistry Dapsone Product Portfolio
7.3.3 Alfa Chemistry Dapsone Production, Value, Price and Gross Margin (2020-2025)
7.3.4 Alfa Chemistry Main Business and Markets Served
7.3.5 Alfa Chemistry Recent Developments/Updates
7.4 Anvia Chemicals
7.4.1 Anvia Chemicals Dapsone Company Information
7.4.2 Anvia Chemicals Dapsone Product Portfolio
7.4.3 Anvia Chemicals Dapsone Production, Value, Price and Gross Margin (2020-2025)
7.4.4 Anvia Chemicals Main Business and Markets Served
7.4.5 Anvia Chemicals Recent Developments/Updates
7.5 Ivy Fine Chemicals
7.5.1 Ivy Fine Chemicals Dapsone Company Information
7.5.2 Ivy Fine Chemicals Dapsone Product Portfolio
7.5.3 Ivy Fine Chemicals Dapsone Production, Value, Price and Gross Margin (2020-2025)
7.5.4 Ivy Fine Chemicals Main Business and Markets Served
7.5.5 Ivy Fine Chemicals Recent Developments/Updates
7.6 AlliChem
7.6.1 AlliChem Dapsone Company Information
7.6.2 AlliChem Dapsone Product Portfolio
7.6.3 AlliChem Dapsone Production, Value, Price and Gross Margin (2020-2025)
7.6.4 AlliChem Main Business and Markets Served
7.6.5 AlliChem Recent Developments/Updates
7.7 Waterstone Technology
7.7.1 Waterstone Technology Dapsone Company Information
7.7.2 Waterstone Technology Dapsone Product Portfolio
7.7.3 Waterstone Technology Dapsone Production, Value, Price and Gross Margin (2020-2025)
7.7.4 Waterstone Technology Main Business and Markets Served
7.7.5 Waterstone Technology Recent Developments/Updates
7.8 Acros Organics
7.8.1 Acros Organics Dapsone Company Information
7.8.2 Acros Organics Dapsone Product Portfolio
7.8.3 Acros Organics Dapsone Production, Value, Price and Gross Margin (2020-2025)
7.8.4 Acros Organics Main Business and Markets Served
7.8.5 Acros Organics Recent Developments/Updates
7.9 3B Scientific
7.9.1 3B Scientific Dapsone Company Information
7.9.2 3B Scientific Dapsone Product Portfolio
7.9.3 3B Scientific Dapsone Production, Value, Price and Gross Margin (2020-2025)
7.9.4 3B Scientific Main Business and Markets Served
7.9.5 3B Scientific Recent Developments/Updates
7.10 EDQM
7.10.1 EDQM Dapsone Company Information
7.10.2 EDQM Dapsone Product Portfolio
7.10.3 EDQM Dapsone Production, Value, Price and Gross Margin (2020-2025)
7.10.4 EDQM Main Business and Markets Served
7.10.5 EDQM Recent Developments/Updates
7.11 J & K SCIENTIFIC
7.11.1 J & K SCIENTIFIC Dapsone Company Information
7.11.2 J & K SCIENTIFIC Dapsone Product Portfolio
7.11.3 J & K SCIENTIFIC Dapsone Production, Value, Price and Gross Margin (2020-2025)
7.11.4 J & K SCIENTIFIC Main Business and Markets Served
7.11.5 J & K SCIENTIFIC Recent Developments/Updates
7.12 Hubei Yuancheng Saichuang Technology
7.12.1 Hubei Yuancheng Saichuang Technology Dapsone Company Information
7.12.2 Hubei Yuancheng Saichuang Technology Dapsone Product Portfolio
7.12.3 Hubei Yuancheng Saichuang Technology Dapsone Production, Value, Price and Gross Margin (2020-2025)
7.12.4 Hubei Yuancheng Saichuang Technology Main Business and Markets Served
7.12.5 Hubei Yuancheng Saichuang Technology Recent Developments/Updates
7.13 Guangzhou Kafen Biotech
7.13.1 Guangzhou Kafen Biotech Dapsone Company Information
7.13.2 Guangzhou Kafen Biotech Dapsone Product Portfolio
7.13.3 Guangzhou Kafen Biotech Dapsone Production, Value, Price and Gross Margin (2020-2025)
7.13.4 Guangzhou Kafen Biotech Main Business and Markets Served
7.13.5 Guangzhou Kafen Biotech Recent Developments/Updates
7.14 Nuray Chemicals
7.14.1 Nuray Chemicals Dapsone Company Information
7.14.2 Nuray Chemicals Dapsone Product Portfolio
7.14.3 Nuray Chemicals Dapsone Production, Value, Price and Gross Margin (2020-2025)
7.14.4 Nuray Chemicals Main Business and Markets Served
7.14.5 Nuray Chemicals Recent Developments/Updates
7.15 Cohance Lifesciences
7.15.1 Cohance Lifesciences Dapsone Company Information
7.15.2 Cohance Lifesciences Dapsone Product Portfolio
7.15.3 Cohance Lifesciences Dapsone Production, Value, Price and Gross Margin (2020-2025)
7.15.4 Cohance Lifesciences Main Business and Markets Served
7.15.5 Cohance Lifesciences Recent Developments/Updates
7.16 HRV Global Life Sciences
7.16.1 HRV Global Life Sciences Dapsone Company Information
7.16.2 HRV Global Life Sciences Dapsone Product Portfolio
7.16.3 HRV Global Life Sciences Dapsone Production, Value, Price and Gross Margin (2020-2025)
7.16.4 HRV Global Life Sciences Main Business and Markets Served
7.16.5 HRV Global Life Sciences Recent Developments/Updates
7.17 Atul Limited
7.17.1 Atul Limited Dapsone Company Information
7.17.2 Atul Limited Dapsone Product Portfolio
7.17.3 Atul Limited Dapsone Production, Value, Price and Gross Margin (2020-2025)
7.17.4 Atul Limited Main Business and Markets Served
7.17.5 Atul Limited Recent Developments/Updates
7.18 Chongqing Huapont Pharmaceutical
7.18.1 Chongqing Huapont Pharmaceutical Dapsone Company Information
7.18.2 Chongqing Huapont Pharmaceutical Dapsone Product Portfolio
7.18.3 Chongqing Huapont Pharmaceutical Dapsone Production, Value, Price and Gross Margin (2020-2025)
7.18.4 Chongqing Huapont Pharmaceutical Main Business and Markets Served
7.18.5 Chongqing Huapont Pharmaceutical Recent Developments/Updates
7.19 Dipharma
7.19.1 Dipharma Dapsone Company Information
7.19.2 Dipharma Dapsone Product Portfolio
7.19.3 Dipharma Dapsone Production, Value, Price and Gross Margin (2020-2025)
7.19.4 Dipharma Main Business and Markets Served
7.19.5 Dipharma Recent Developments/Updates
7.20 Lundbeck Pharma
7.20.1 Lundbeck Pharma Dapsone Company Information
7.20.2 Lundbeck Pharma Dapsone Product Portfolio
7.20.3 Lundbeck Pharma Dapsone Production, Value, Price and Gross Margin (2020-2025)
7.20.4 Lundbeck Pharma Main Business and Markets Served
7.20.5 Lundbeck Pharma Recent Developments/Updates
7.21 Corden Pharma
7.21.1 Corden Pharma Dapsone Company Information
7.21.2 Corden Pharma Dapsone Product Portfolio
7.21.3 Corden Pharma Dapsone Production, Value, Price and Gross Margin (2020-2025)
7.21.4 Corden Pharma Main Business and Markets Served
7.21.5 Corden Pharma Recent Developments/Updates
7.22 Macleods Pharmaceuticals
7.22.1 Macleods Pharmaceuticals Dapsone Company Information
7.22.2 Macleods Pharmaceuticals Dapsone Product Portfolio
7.22.3 Macleods Pharmaceuticals Dapsone Production, Value, Price and Gross Margin (2020-2025)
7.22.4 Macleods Pharmaceuticals Main Business and Markets Served
7.22.5 Macleods Pharmaceuticals Recent Developments/Updates
7.23 Healthy Life Pharma
7.23.1 Healthy Life Pharma Dapsone Company Information
7.23.2 Healthy Life Pharma Dapsone Product Portfolio
7.23.3 Healthy Life Pharma Dapsone Production, Value, Price and Gross Margin (2020-2025)
7.23.4 Healthy Life Pharma Main Business and Markets Served
7.23.5 Healthy Life Pharma Recent Developments/Updates
8 Industry Chain and Sales Channels Analysis
8.1 Dapsone Industry Chain Analysis
8.2 Dapsone Raw Material Supply Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.3 Dapsone Production Mode & Process Analysis
8.4 Dapsone Sales and Marketing
8.4.1 Dapsone Sales Channels
8.4.2 Dapsone Distributors
8.5 Dapsone Customer Analysis
9 Dapsone Market Dynamics
9.1 Dapsone Industry Trends
9.2 Dapsone Market Drivers
9.3 Dapsone Market Challenges
9.4 Dapsone Market Restraints
10 Research Findings and Conclusion
11 Methodology and Data Source
11.1 Methodology/Research Approach
11.1.1 Research Programs/Design
11.1.2 Market Size Estimation
11.1.3 Market Breakdown and Data Triangulation
11.2 Data Source
11.2.1 Secondary Sources
11.2.2 Primary Sources
11.3 Author List
11.4 Disclaimer
TCI
HBCChem
Alfa Chemistry
Anvia Chemicals
Ivy Fine Chemicals
AlliChem
Waterstone Technology
Acros Organics
3B Scientific
EDQM
J & K SCIENTIFIC
Hubei Yuancheng Saichuang Technology
Guangzhou Kafen Biotech
Nuray Chemicals
Cohance Lifesciences
HRV Global Life Sciences
Atul Limited
Chongqing Huapont Pharmaceutical
Dipharma
Lundbeck Pharma
Corden Pharma
Macleods Pharmaceuticals
Healthy Life Pharma
听
听
*If Applicable.
